Release Date: 21/08/18 09:57 Summary: FY18 Results and Capital Raising Presentation Price Sensitive: No Download Document 1.87MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%